{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:54:16Z","timestamp":1791474856494,"version":"4.3.4"},"reference-count":42,"publisher":"American Academy of Pediatrics (AAP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,6,1]]},"abstract":"<jats:p>OBJECTIVES. The purpose of this work was to determine whether the reported association between neonatal morbidities and a patent ductus arteriosus is because of the left-to-right patent ductus arteriosus shunt itself, the therapies used to treat it, or the immaturity of the infants who are likely to develop a patent ductus arteriosus.<\/jats:p>\n               <jats:p>METHODS. A total of 446 infants (&amp;lt;28 weeks' gestation) were treated with the same patent ductus arteriosus care\u2013oriented protocol, and logistic regression analysis was used to examine the effects of several patent ductus arteriosus\u2013related variables (presence of a symptomatic patent ductus arteriosus, the number of indomethacin doses used, the ductus response to indomethacin, and the use of surgical ligation) on the incidence of retinopathy of prematurity, necrotizing enterocolitis, chronic lung disease, death, and neurodevelopmental impairment.<\/jats:p>\n               <jats:p>RESULTS. Most of the predictive effects that the presence of a patent ductus arteriosus and its treatment had on neonatal morbidity could be accounted for by the infants' immature gestation. Use of surgical ligation, however, was significantly associated with the development of chronic lung disease and was independent of immature gestation, other patent ductus arteriosus\u2013related variables, or other perinatal and neonatal risk factors known to be associated with chronic lung disease.<\/jats:p>\n               <jats:p>CONCLUSIONS. These findings add to the growing uncertainty about the benefits and risks of surgical ligation during the neonatal period.<\/jats:p>","DOI":"10.1542\/peds.2006-3124","type":"journal-article","created":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T16:36:04Z","timestamp":1180715764000},"page":"1165-1174","source":"Crossref","is-referenced-by-count":186,"title":["Patent Ductus Arteriosus and Its Treatment as Risk Factors for Neonatal and Neurodevelopmental Morbidity"],"prefix":"10.1542","volume":"119","author":[{"given":"Nancy","family":"Chorne","sequence":"first","affiliation":[{"name":"Department of Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Leonard","sequence":"additional","affiliation":[{"name":"Department of Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Piecuch","sequence":"additional","affiliation":[{"name":"Department of Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald I.","family":"Clyman","sequence":"additional","affiliation":[{"name":"Department of Pediatrics"},{"name":"Cardiovascular Research Institute, University of California, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2007,6,1]]},"reference":[{"key":"2021120902023252400_R1","doi-asserted-by":"crossref","unstructured":"Laughon MM, Simmons MA, Bose CL. Patency of the ductus arteriosus in the premature infant: is it pathologic? Should it be treated?Curr Opin Pediatr.\u20082004;16:146\u2013151","DOI":"10.1097\/00008480-200404000-00005"},{"key":"2021120902023252400_R2","doi-asserted-by":"crossref","unstructured":"Bose CL, Laughon M. Treatment to prevent patency of the ductus arteriosus: beneficial or harmful?J Pediatr.\u20082006;148:713\u2013714","DOI":"10.1016\/j.jpeds.2006.03.015"},{"key":"2021120902023252400_R3","doi-asserted-by":"crossref","unstructured":"Arroe M, Peitersen B. Retinopathy of prematurity: review of a seven-year period in a Danish neonatal intensive care unit. Acta Paediatr.\u20081994;83:501\u2013505","DOI":"10.1111\/j.1651-2227.1994.tb13067.x"},{"key":"2021120902023252400_R4","doi-asserted-by":"crossref","unstructured":"Marshall DD, Kotelchuck M, Young TE, Bose CL, Kruyer L, O'Shea TM. Risk factors for chronic lung disease in the surfactant era: a North Carolina population-based study of very low birth weight infants. North Carolina Neonatologists Association. Pediatrics.\u20081999;104:1345\u20131350","DOI":"10.1542\/peds.104.6.1345"},{"key":"2021120902023252400_R5","doi-asserted-by":"crossref","unstructured":"Tapia JL, Agost D, Alegria A, et al. Bronchopulmonary dysplasia: incidence, risk factors and resource use in a population of South American very low birth weight infants[in Portugese]. J Pediatr (Rio J).\u20082006;82:15\u201320","DOI":"10.2223\/JPED.1431"},{"key":"2021120902023252400_R6","doi-asserted-by":"crossref","unstructured":"Higgins RD, Mendelsohn AL, DeFeo MJ, Ucsel R, Hendricks-Munoz KD. Antenatal dexamethasone and decreased severity of retinopathy of prematurity. Arch Ophthalmol.\u20081998;116:601\u2013605","DOI":"10.1001\/archopht.116.5.601"},{"key":"2021120902023252400_R7","doi-asserted-by":"crossref","unstructured":"Cotton RB, Stahlman MT, Berder HW, Graham TP, Catterton WZ, Kover I. Randomized trial of early closure of symptomatic patent ductus arteriosus in small preterm infants. J Pediatr.\u20081978;93:647\u2013651","DOI":"10.1016\/S0022-3476(78)80910-X"},{"key":"2021120902023252400_R8","doi-asserted-by":"crossref","unstructured":"Kaapa P, Lanning P, Koivisto M. Early closure of patent ductus arteriosus with indomethacin in preterm infants with idiopathic respiratory distress syndrome. Acta Paediatr Scand.\u20081983;72:179\u2013184","DOI":"10.1111\/j.1651-2227.1983.tb09693.x"},{"key":"2021120902023252400_R9","doi-asserted-by":"crossref","unstructured":"Dollberg S, Lusky A, Reichman B. Patent ductus arteriosus, indomethacin and necrotizing enterocolitis in very low birth weight infants: a population-based study. J Pediatr Gastroenterol Nutr.\u20082005;40:184\u2013188","DOI":"10.1097\/00005176-200502000-00019"},{"key":"2021120902023252400_R10","doi-asserted-by":"crossref","unstructured":"Alpan GM, Eyal F, Vinograd I, et al. Localized intestinal perforations after enteral administration of indomethacin in premature infants. J Pediatr.\u20081985;106:277\u2013281","DOI":"10.1016\/S0022-3476(85)80305-X"},{"key":"2021120902023252400_R11","doi-asserted-by":"crossref","unstructured":"Fowlie PW, Davis PG. Prophylactic indomethacin for preterm infants: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed.\u20082003;88:F464\u2013F466","DOI":"10.1136\/fn.88.6.F464"},{"key":"2021120902023252400_R12","doi-asserted-by":"crossref","unstructured":"Cooke L, Steer P, Woodgate P. Indomethacin for asymptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev.\u20082003;(2):CD003745","DOI":"10.1002\/14651858.CD003745"},{"key":"2021120902023252400_R13","doi-asserted-by":"crossref","unstructured":"Van Overmeire B, Van de Broek H, Van Laer P, Weyler J, Vanhaesebrouck P. Early versus late indomethacin treatment for patent ductus arteriosus in premature infants with respiratory distress syndrome. J Pediatr.\u20082001;138:205\u2013211","DOI":"10.1067\/mpd.2001.110528"},{"key":"2021120902023252400_R14","doi-asserted-by":"crossref","unstructured":"Schmidt B, Roberts RS, Fanaroff A, et al. Indomethacin prophylaxis, patent ductus arteriosus, and the risk of bronchopulmonary dysplasia: further analyses from the Trial of Indomethacin Prophylaxis in Preterms (TIPP). J Pediatr.\u20082006;148:730\u2013734","DOI":"10.1016\/j.jpeds.2006.01.047"},{"key":"2021120902023252400_R15","unstructured":"Herrera C, Holberton J, Davis P. Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev.\u20082004;(1):CD003480"},{"key":"2021120902023252400_R16","doi-asserted-by":"crossref","unstructured":"Hammerman C, Aranburo MJ. Prolonged indomethacin therapy for the prevention of recurrences of patent ductus arteriosus. J Pediatr.\u20081990;117:771\u2013776","DOI":"10.1016\/S0022-3476(05)83342-6"},{"key":"2021120902023252400_R17","doi-asserted-by":"crossref","unstructured":"Mellander M, Leheup B, Lindstrom DP, et al. Recurrence of symptomatic patent ductus arteriosus in extremely premature infants, treated with indomethacin. J Pediatr.\u20081984;105:138\u2013143","DOI":"10.1016\/S0022-3476(84)80380-7"},{"key":"2021120902023252400_R18","doi-asserted-by":"crossref","unstructured":"Weiss H, Cooper B, Brook M, Schlueter M, Clyman RI. Factors determining reopening of the ductus arteriosus after successful clinical closure with indomethacin. J Pediatr.\u20081995;127:466\u2013471","DOI":"10.1016\/S0022-3476(95)70084-6"},{"key":"2021120902023252400_R19","doi-asserted-by":"crossref","unstructured":"Gersony WM, Peckham GJ, Ellison RC, Miettinen OS, Nadas AS. Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study. J Pediatr.\u20081983;102:895\u2013906","DOI":"10.1016\/S0022-3476(83)80022-5"},{"key":"2021120902023252400_R20","doi-asserted-by":"crossref","unstructured":"Moin F, Kennedy KA, Moya FR. Risk factors predicting vasopressor use after patent ductus arteriosus ligation. Am J Perinatol.\u20082003;20:313\u2013320","DOI":"10.1055\/s-2003-42693"},{"key":"2021120902023252400_R21","doi-asserted-by":"crossref","unstructured":"Cassady G, Crouse DT, Kirklin JW, et al. A randomized, controlled trial of very early prophylactic ligation of the ductus arteriosus in babies who weighed 1000 g or less at birth. N Engl J Med.\u20081989;320:1511\u20131516","DOI":"10.1056\/NEJM198906083202302"},{"key":"2021120902023252400_R22","doi-asserted-by":"crossref","unstructured":"Serwer GA, Armstrong BE, Anderson PA. Continuous wave Doppler ultrasonographic quantitation of patent ductus arteriosus flow. J Pediatr.\u20081982;100:297\u2013299","DOI":"10.1016\/S0022-3476(82)80658-6"},{"key":"2021120902023252400_R23","doi-asserted-by":"crossref","unstructured":"Keller RL, Clyman RI. Persistent Doppler flow predicts lack of response to multiple courses of indomethacin in premature infants with recurrent patent ductus arteriosus. Pediatrics.\u20082003;112:583\u2013587","DOI":"10.1542\/peds.112.3.583"},{"key":"2021120902023252400_R24","doi-asserted-by":"crossref","unstructured":"Bell MJ, Ternberg JL, Feigin RD, et al. Neonatal necrotizing enterocolitis: therapeutic decisions based upon clinical staging. Ann Surg.\u20081978;187:1\u20137","DOI":"10.1097\/00000658-197801000-00001"},{"key":"2021120902023252400_R25","doi-asserted-by":"crossref","unstructured":"Good WV, Hardy RJ, Dobson V, et al. The incidence and course of retinopathy of prematurity: findings from the early treatment for retinopathy of prematurity study. Pediatrics.\u20082005;116:15\u201323","DOI":"10.1542\/peds.2004-1413"},{"key":"2021120902023252400_R26","doi-asserted-by":"crossref","unstructured":"Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weight &lt; 1500 grams. J Pediatr.\u20081978;92:529\u2013534","DOI":"10.1016\/S0022-3476(78)80282-0"},{"key":"2021120902023252400_R27","doi-asserted-by":"crossref","unstructured":"Piecuch RE, Leonard CH, Cooper BA, Kilpatrick SJ, Schlueter MA, Sola A. Outcome of infants born at 24\u201326 weeks' gestation: II. Neurodevelopmental outcome. Obstet Gynecol.\u20081997;90:809\u2013814","DOI":"10.1016\/S0029-7844(97)00429-8"},{"key":"2021120902023252400_R28","doi-asserted-by":"crossref","unstructured":"Miller SP, Ferriero DM, Leonard C, et al. Early brain injury in premature newborns detected with magnetic resonance imaging is associated with adverse early neurodevelopmental outcome. J Pediatr.\u20082005;147:609\u2013616","DOI":"10.1016\/j.jpeds.2005.06.033"},{"key":"2021120902023252400_R29","doi-asserted-by":"crossref","unstructured":"Schmidt B, Davis P, Moddemann D, et al. Long-term effects of indomethacin prophylaxis in extremely-low-birth- weight infants. N Engl J Med.\u20082001;344:1966\u20131972","DOI":"10.1056\/NEJM200106283442602"},{"key":"2021120902023252400_R30","doi-asserted-by":"crossref","unstructured":"Clyman RI. Recommendations for the postnatal use of indomethacin. An analysis of four separate treatment strategies. J Pediatr.\u20081996;128:601\u2013607","DOI":"10.1016\/S0022-3476(96)80123-5"},{"key":"2021120902023252400_R31","doi-asserted-by":"crossref","unstructured":"Brooks JM, Travadi JN, Patole SK, Doherty DA, Simmer K. Is surgical ligation of patent ductus arteriosus necessary? The Western Australian experience of conservative management. Arch Dis Child Fetal Neonatal Ed.\u20082005;90:F235\u2013F239","DOI":"10.1136\/adc.2004.057638"},{"key":"2021120902023252400_R32","doi-asserted-by":"crossref","unstructured":"Jaillard S, Larrue B, Rakza T, Magnenant E, Warembourg H, Storme L. Consequences of delayed surgical closure of patent ductus arteriosus in very premature infants. Ann Thorac Surg.\u20082006;81:231\u2013234","DOI":"10.1016\/j.athoracsur.2005.03.141"},{"key":"2021120902023252400_R33","doi-asserted-by":"crossref","unstructured":"Waleh N, Kajino H, Marrache AM, et al. Prostaglandin E2-mediated relaxation of the ductus arteriosus: effects of gestational age on g protein-coupled receptor expression, signaling, and vasomotor control. Circulation.\u20082004;110:2326\u20132332","DOI":"10.1161\/01.CIR.0000145159.16637.5D"},{"key":"2021120902023252400_R34","doi-asserted-by":"crossref","unstructured":"Narayanan M, Cooper B, Weiss H, Clyman RI. Prophylactic indomethacin: factors determining permanent ductus arteriosus closure. J Pediatr.\u20082000;136:330\u2013337","DOI":"10.1067\/mpd.2000.103414"},{"key":"2021120902023252400_R35","doi-asserted-by":"crossref","unstructured":"Smith LE. IGF-1 and retinopathy of prematurity in the preterm infant. Biol Neonate.\u20082005;88:237\u2013244","DOI":"10.1159\/000087587"},{"key":"2021120902023252400_R36","doi-asserted-by":"crossref","unstructured":"Crissinger KD, Granger DN. Characterization of intestinal collateral blood flow in the developing piglet. Pediatr Res.\u20081988;24:473\u2013476","DOI":"10.1203\/00006450-198810000-00011"},{"key":"2021120902023252400_R37","doi-asserted-by":"crossref","unstructured":"Jobe AJ. The new BPD: an arrest of lung development. Pediatr Res.\u20081999;46:641\u2013643","DOI":"10.1203\/00006450-199912000-00007"},{"key":"2021120902023252400_R38","doi-asserted-by":"crossref","unstructured":"Andre P, Thebaud B, Delavaucoupet J, et al. Late-onset cystic periventricular leukomalacia in premature infants: a threat until term. Am J Perinatol.\u20082001;18:79\u201386","DOI":"10.1055\/s-2001-13633"},{"key":"2021120902023252400_R39","doi-asserted-by":"crossref","unstructured":"Doyle LW. Outcome at 5 years of age of children 23 to 27 weeks' gestation: refining the prognosis. Pediatrics.\u20082001;108:134\u2013141","DOI":"10.1542\/peds.108.1.134"},{"key":"2021120902023252400_R40","doi-asserted-by":"crossref","unstructured":"Victorian Infant Collaborative Study Group. Surgery and the tiny baby: sensorineural outcome at 5 years of age. J Paediatr Child Health.\u20081996;32:167\u2013172","DOI":"10.1111\/j.1440-1754.1996.tb00916.x"},{"key":"2021120902023252400_R41","doi-asserted-by":"crossref","unstructured":"Clyman RI. Mechanisms regulating the ductus arteriosus. Biol Neonate.\u20082006;89:330\u2013335","DOI":"10.1159\/000092870"},{"key":"2021120902023252400_R42","doi-asserted-by":"crossref","unstructured":"McCurnin DC, Yoder BA, Coalson J, et al. Effect of ductus ligation on cardiopulmonary function in premature baboons. Am J Respir Crit Care Med.\u20082005;172:1569\u20131574","DOI":"10.1164\/rccm.200502-230OC"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/119\/6\/1165\/1119807\/zpe00607001165.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/119\/6\/1165\/1119807\/zpe00607001165.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T08:56:15Z","timestamp":1639040175000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/119\/6\/1165\/70632\/Patent-Ductus-Arteriosus-and-Its-Treatment-as-Risk"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,1]]},"references-count":42,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2007,6,1]]},"published-print":{"date-parts":[[2007,6,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2006-3124","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6,1]]}}}